These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31787321)

  • 21. Association of Short-Term Mortality of Venous Thromboembolism with Family History of Venous Thromboembolism and Charlson Comorbidity Index.
    Zöller B; Pirouzifard M; Sundquist J; Sundquist K
    Thromb Haemost; 2019 Jan; 119(1):48-55. PubMed ID: 30597499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Basal high-sensitivity-C-reactive protein levels in patients with spontaneous venous thromboembolism.
    Vormittag R; Vukovich T; Schönauer V; Lehr S; Minar E; Bialonczyk C; Hirschl M; Pabinger I
    Thromb Haemost; 2005 Mar; 93(3):488-93. PubMed ID: 15735799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function.
    Kovářová M; Koller T; Štvrtinová V; Payer J
    Endokrynol Pol; 2015; 66(6):474-9. PubMed ID: 26662645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron deficiency: a novel risk factor of recurrence in patients after unprovoked venous thromboembolism.
    Potaczek DP; Jankowska EA; Wypasek E; Undas A
    Pol Arch Med Wewn; 2016; 126(3):159-65. PubMed ID: 26942727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores.
    Lecumberri R; Jiménez L; Ruiz-Artacho P; Nieto JA; Ruiz-Giménez N; Visonà A; Skride A; Moustafa F; Trujillo J; Monreal M;
    TH Open; 2021 Jul; 5(3):e319-e328. PubMed ID: 34568742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between smoking and recurrence of venous thromboembolism and bleeding in elderly patients with past acute venous thromboembolism.
    Carruzzo P; Méan M; Limacher A; Aujesky D; Cornuz J; Clair C
    Thromb Res; 2016 Feb; 138():74-79. PubMed ID: 26688323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simplified stratification system for venous thromboembolism risk in severely injured trauma patients.
    Meizoso JP; Karcutskie CA; Ray JJ; Ruiz X; Ginzburg E; Namias N; Schulman CI; Proctor KG
    J Surg Res; 2017 Jan; 207():138-144. PubMed ID: 27979470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
    Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study.
    Kraaijpoel N; van Es N; Raskob GE; Büller HR; Carrier M; Zhang G; Lin M; Grosso MA; Di Nisio M
    Thromb Haemost; 2018 Jul; 118(7):1270-1278. PubMed ID: 29864787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
    Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
    J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein concentration as a risk predictor of mortality in intensive care unit: a multicenter, prospective, observational study.
    Qu R; Hu L; Ling Y; Hou Y; Fang H; Zhang H; Liang S; He Z; Fang M; Li J; Li X; Chen C
    BMC Anesthesiol; 2020 Nov; 20(1):292. PubMed ID: 33225902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
    Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
    Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N
    Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study.
    Nurmohamed NS; Collard D; Reeskamp LF; Kaiser Y; Kroon J; Tromp TR; ; van den Born BH; Coppens M; Vlaar APJ; Beudel M; van de Beek D; van Es N; Moriarty PM; Tsimikas S; Stroes ESG
    Atherosclerosis; 2022 Jan; 341():43-49. PubMed ID: 34995986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
    Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamic changes of inflammation-related indices in venous thromboembolism and the association between these indices and venous thromboembolism].
    Liu FF; Zhai ZG; Yang YH; Wang J; Wang C
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(24):1860-3. PubMed ID: 24124734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
    Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
    Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
    Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of guidelines for injured children at high risk for venous thromboembolism: A prospective observational study.
    Landisch RM; Hanson SJ; Cassidy LD; Braun K; Punzalan RC; Gourlay DM
    J Trauma Acute Care Surg; 2017 May; 82(5):836-844. PubMed ID: 28430759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.